JP Patent

JP6537601B2 — アザ二環式化合物の結晶

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2019-07-03 · 7y expired

What this patent protects

Patent listed against Lytgobi.

Drugs covered by this patent

Lytgobi (futibatinib) · Taiho Oncology

Patent Metadata

Patent number: JP6537601B2
Jurisdiction: JP
Classification: —
Expires: 2019-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Taiho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.